These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2142756)

  • 1. Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes.
    Sultan Y; London GM; Goldfarb B; Toulon P; Marchais SJ
    Nephrol Dial Transplant; 1990; 5(5):362-8. PubMed ID: 2142756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
    Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
    Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes.
    Seyfert UT; Helmling E; Hauck W; Skroch D; Albert W
    Nephrol Dial Transplant; 1991; 6(6):428-34. PubMed ID: 1876284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers.
    Mulvihill J; Crost T; Renaux JL; Cazenave JP
    Nephrol Dial Transplant; 1997 Sep; 12(9):1968-73. PubMed ID: 9306352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin is unable to prevent contact activation by three different membranes.
    Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
    Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
    Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation.
    De Sanctis LB; Stefoni S; Cianciolo G; Colì L; Buscaroli A; Feliciangeli G; Borgnino LC; Bonetti M; Gregorini MC; De Giovanni P; Buttazzi R
    Int J Artif Organs; 1996 Jul; 19(7):404-10. PubMed ID: 8841854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis membranes and coagulation system.
    Notohamiprodjo M; Andrassy K; Bommer J; Ritz E
    Blood Purif; 1986; 4(1-3):130-41. PubMed ID: 2942155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
    Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes.
    Reber G; Stoermann C; de Moerloose P; Ruedin P; Leski M
    Int J Artif Organs; 1992 May; 15(5):269-76. PubMed ID: 1601510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
    Seeber C; Hiller E; Holler E; Kolb HJ
    Thromb Res; 1992 May; 66(4):373-83. PubMed ID: 1412203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.